Abstract
In a randomized, placebo-controlled, double-blind study, the efficacy and safety of clobazam and diazepam were compared in 114 anxious outpatients. During the 4-week double-blind phase of the study, the mean daily dose was 59 mg for clobazam and 25 mg for diazepam. Results indicate statistically significant efficacy, measured by both patient and physician rating scales, for both active drugs compared to placebo. The incidence of sedation was similar for the two active treatment groups; dizziness was more frequent in the diazepam group.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 296-300 |
| Number of pages | 5 |
| Journal | Journal of Clinical Psychiatry |
| Volume | 44 |
| Issue number | 8 I |
| State | Published - Jan 1 1983 |
ASJC Scopus subject areas
- Psychiatry and Mental health
Fingerprint Dive into the research topics of 'A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety'. Together they form a unique fingerprint.
Cite this
Jacobson, A. F., Goldstein, B. J., Dominguez, R. A., & Steinbook, R. M. (1983). A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety. Journal of Clinical Psychiatry, 44(8 I), 296-300.